Role of carboxyl tail of the rat angiotensin II type 1A receptor in agonist-induced internalization of the receptor. 1994

S Chaki, and D F Guo, and Y Yamano, and K Ohyama, and M Tani, and M Mizukoshi, and H Shirai, and T Inagami
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee.

Binding of angiotensin II (Ang II) to its receptor type 1A (AT1A) is known to trigger its internalization. We studied the role of cytosolic segments of AT1A in the internalization, and obtained results indicating a functional role of the cytosolic carboxyl terminal tail of AT1A in the internalization. Deletion of 50 amino acids from the carboxyl terminus abolished the receptor internalization. Deletion mutants lacking 13 and 32 amino acid residues in the carboxyl terminal cytosolic region were internalized to the same extent as wild type AT1A; however, internalization of a mutant lacking the last 42 residues was partially suppressed. Thus, residues 310 through 327 were shown to be essential for the internalization. We propose that a short domain in the cytoplasmic tail (residues 310 to 327) may play a dominant role in the agonist-induced receptor internalization of AT1A. Our results also suggest that the molecular determinants of the AT1A receptor involved in receptor internalization are distinct from those participating in the desensitization process.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections

Related Publications

S Chaki, and D F Guo, and Y Yamano, and K Ohyama, and M Tani, and M Mizukoshi, and H Shirai, and T Inagami
March 1998, Circulation research,
S Chaki, and D F Guo, and Y Yamano, and K Ohyama, and M Tani, and M Mizukoshi, and H Shirai, and T Inagami
September 1997, The Journal of biological chemistry,
S Chaki, and D F Guo, and Y Yamano, and K Ohyama, and M Tani, and M Mizukoshi, and H Shirai, and T Inagami
June 1995, The Journal of steroid biochemistry and molecular biology,
S Chaki, and D F Guo, and Y Yamano, and K Ohyama, and M Tani, and M Mizukoshi, and H Shirai, and T Inagami
October 2001, Molecular endocrinology (Baltimore, Md.),
S Chaki, and D F Guo, and Y Yamano, and K Ohyama, and M Tani, and M Mizukoshi, and H Shirai, and T Inagami
March 2002, The Journal of biological chemistry,
S Chaki, and D F Guo, and Y Yamano, and K Ohyama, and M Tani, and M Mizukoshi, and H Shirai, and T Inagami
February 2004, Molecular pharmacology,
S Chaki, and D F Guo, and Y Yamano, and K Ohyama, and M Tani, and M Mizukoshi, and H Shirai, and T Inagami
July 2002, Hypertension research : official journal of the Japanese Society of Hypertension,
S Chaki, and D F Guo, and Y Yamano, and K Ohyama, and M Tani, and M Mizukoshi, and H Shirai, and T Inagami
January 2013, PloS one,
S Chaki, and D F Guo, and Y Yamano, and K Ohyama, and M Tani, and M Mizukoshi, and H Shirai, and T Inagami
December 2003, Molecular pharmacology,
S Chaki, and D F Guo, and Y Yamano, and K Ohyama, and M Tani, and M Mizukoshi, and H Shirai, and T Inagami
November 2014, The Journal of biological chemistry,
Copied contents to your clipboard!